[go: up one dir, main page]

SE9001269D0 - 2-substituted n,n-ditrimethoxybenzoyl piperazines,a preparation process of the same and therapeutic compositions containing them - Google Patents

2-substituted n,n-ditrimethoxybenzoyl piperazines,a preparation process of the same and therapeutic compositions containing them

Info

Publication number
SE9001269D0
SE9001269D0 SE9001269A SE9001269A SE9001269D0 SE 9001269 D0 SE9001269 D0 SE 9001269D0 SE 9001269 A SE9001269 A SE 9001269A SE 9001269 A SE9001269 A SE 9001269A SE 9001269 D0 SE9001269 D0 SE 9001269D0
Authority
SE
Sweden
Prior art keywords
preparation process
compositions containing
therapeutic compositions
carbon atoms
ditrimethoxybenzoyl
Prior art date
Application number
SE9001269A
Other languages
English (en)
Other versions
SE9001269L (sv
SE505186C2 (sv
Inventor
P Braquet
Original Assignee
Scras
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scras filed Critical Scras
Publication of SE9001269D0 publication Critical patent/SE9001269D0/sv
Publication of SE9001269L publication Critical patent/SE9001269L/sv
Publication of SE505186C2 publication Critical patent/SE505186C2/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182Radicals derived from carboxylic acids
    • C07D295/192Radicals derived from carboxylic acids from aromatic carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/12Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SE9001269A 1989-04-15 1990-04-06 2-substituerade N,N'-di(trimetoxibensoyl)piperaziner, förfarande för framställning därav samt terapeutiska kompositioner innehållande dessa SE505186C2 (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898908587A GB8908587D0 (en) 1989-04-15 1989-04-15 New 2-substituted n,n'-ditrimethoxybenzoyl piperazines

Publications (3)

Publication Number Publication Date
SE9001269D0 true SE9001269D0 (sv) 1990-04-06
SE9001269L SE9001269L (sv) 1990-10-16
SE505186C2 SE505186C2 (sv) 1997-07-14

Family

ID=10655129

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9001269A SE505186C2 (sv) 1989-04-15 1990-04-06 2-substituerade N,N'-di(trimetoxibensoyl)piperaziner, förfarande för framställning därav samt terapeutiska kompositioner innehållande dessa

Country Status (32)

Country Link
US (1) US5019576A (sv)
JP (1) JP2633709B2 (sv)
KR (1) KR900016178A (sv)
AR (1) AR247736A1 (sv)
AT (1) AT399337B (sv)
AU (1) AU631334B2 (sv)
BE (1) BE1007245A3 (sv)
CA (1) CA2014521C (sv)
CH (1) CH681301A5 (sv)
DE (1) DE4011925A1 (sv)
DK (1) DK91890A (sv)
DZ (1) DZ1407A1 (sv)
ES (1) ES2019554A6 (sv)
FI (1) FI92058C (sv)
FR (2) FR2645859B1 (sv)
GB (2) GB8908587D0 (sv)
GR (1) GR1000355B (sv)
HK (1) HK95092A (sv)
IE (1) IE65058B1 (sv)
IN (1) IN175799B (sv)
IT (1) IT1241631B (sv)
LU (1) LU87719A1 (sv)
MA (1) MA21805A1 (sv)
NL (1) NL9000798A (sv)
NO (1) NO176098C (sv)
NZ (1) NZ233250A (sv)
OA (1) OA09446A (sv)
PT (1) PT93736B (sv)
SE (1) SE505186C2 (sv)
SG (1) SG92092G (sv)
TN (1) TNSN90051A1 (sv)
ZA (1) ZA902566B (sv)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5344830A (en) * 1992-12-10 1994-09-06 Merck & Co., Inc. N,N-diacylpiperazine tachykinin antagonists
US5883098A (en) * 1993-11-29 1999-03-16 Fujisawa Pharmaceutical Co., Ltd. Piperazine derivatives
IL111730A (en) * 1993-11-29 1998-12-06 Fujisawa Pharmaceutical Co Piperazine derivatives processes for the preparation thereof and pharmaceutical compositions containing the same
US5610165A (en) * 1994-02-17 1997-03-11 Merck & Co., Inc. N-acylpiperidine tachykinin antagonists
US5795894A (en) * 1995-05-02 1998-08-18 Schering Corporation Piperazino derivatives as neurokinn antagonists
CN1111528C (zh) * 1995-05-02 2003-06-18 先灵公司 用作神经激肽拮抗药的哌嗪衍生物
US5892039A (en) * 1995-08-31 1999-04-06 Schering Corporation Piperazino derivatives as neurokinin antagonists
BR9610277A (pt) * 1995-08-31 1999-07-06 Schering Corp Derivados de piperazino como antagonistas de neurowuinina
US5869488A (en) * 1996-05-01 1999-02-09 Schering Corporation Piperazino derivatives as neurokinin antagonists
FR2780649B1 (fr) * 1998-07-06 2001-03-09 Univ Paris Vii Denis Diderot Derives de la piperazine pour l'inhibition de la replication du virus de l'immunodeficience humaine

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1243991A (en) * 1968-06-10 1971-08-25 Ici Ltd Piperidine, morpholine and piperazine derivatives
FR2209560A1 (en) * 1972-12-07 1974-07-05 Degussa N-(Trialkoxyaroyl)-ethylenediamine derivs - useful as cardioactive medicaments, exhibit anti-ischaemic activity comparable to nitroglycerin
IL85700A0 (en) * 1987-03-24 1988-08-31 Takeda Chemical Industries Ltd 1,4-disubstituted piperazine compounds,their production and use
US4937246A (en) * 1987-11-25 1990-06-26 Takeda Chemical Industries, Ltd. PAF antagonist, 1,4-disubstituted piperazine compounds and production thereof
PT90619B (pt) * 1988-05-23 1994-10-31 Glaxo Group Ltd Processo para a preparacao de compostos de piperazina
GB8823775D0 (en) * 1988-10-11 1988-11-16 Scras New 2-carbonyl substituted n n'-di-(trimethoxybenzoyl)piperazines
GB8823776D0 (en) * 1988-10-11 1988-11-16 Scras New 2-methoxycarbonyl sustituted n n'-di-(trimethoxybenzoyl)piperazines
US4997836A (en) * 1988-11-11 1991-03-05 Takeda Chemical Industries, Ltd. Trisubstituted piperazine compounds, their production and use

Also Published As

Publication number Publication date
FR2645859A1 (fr) 1990-10-19
LU87719A1 (fr) 1990-07-24
NO176098B (no) 1994-10-24
FI92058B (sv) 1994-06-15
DK91890A (da) 1990-10-16
FR2645743A1 (fr) 1990-10-19
ES2019554A6 (es) 1991-06-16
ZA902566B (en) 1991-01-30
IE901314L (en) 1990-10-15
FI901883A0 (sv) 1990-04-12
GR900100270A (en) 1991-09-27
DK91890D0 (da) 1990-04-11
US5019576A (en) 1991-05-28
SG92092G (en) 1992-12-04
KR900016178A (ko) 1990-11-12
BE1007245A3 (fr) 1995-05-02
NO901631L (no) 1990-10-16
GB2230262B (en) 1992-02-26
AU631334B2 (en) 1992-11-19
FR2645743B1 (fr) 1992-06-05
FR2645859B1 (fr) 1992-06-05
AR247736A1 (es) 1995-03-31
GB8908587D0 (en) 1989-06-01
MA21805A1 (fr) 1990-12-31
AT399337B (de) 1995-04-25
PT93736A (pt) 1990-11-20
ATA86690A (de) 1994-09-15
CA2014521C (en) 1997-09-09
NL9000798A (nl) 1990-11-01
SE9001269L (sv) 1990-10-16
OA09446A (fr) 1992-10-15
DE4011925A1 (de) 1990-10-18
JPH02292266A (ja) 1990-12-03
AU5326190A (en) 1990-11-01
IN175799B (sv) 1995-08-26
GB2230262A (en) 1990-10-17
NO901631D0 (no) 1990-04-10
FI92058C (sv) 1994-09-26
JP2633709B2 (ja) 1997-07-23
PT93736B (pt) 1996-09-30
HK95092A (en) 1992-12-04
TNSN90051A1 (fr) 1991-03-05
NZ233250A (en) 1991-03-26
CA2014521A1 (en) 1990-10-15
CH681301A5 (sv) 1993-02-26
IT9020020A1 (it) 1991-10-12
IE65058B1 (en) 1995-10-04
IT1241631B (it) 1994-01-25
GB9007612D0 (en) 1990-05-30
NO176098C (no) 1995-02-01
GR1000355B (el) 1992-06-25
DZ1407A1 (fr) 2004-09-13
IT9020020A0 (it) 1990-04-12
SE505186C2 (sv) 1997-07-14

Similar Documents

Publication Publication Date Title
ES2044836T3 (es) Derivado de la piperidina, su utilizacion y compuesto farmaceutico que lo contiene.
MY129970A (en) Hypolipidaemic compounds
BR9004698A (pt) Derivados de 4-benzoil-isoxazol
MX9306831A (es) Nuevos compuestos heterociclicos.
ES2121441T3 (es) Nuevos derivados de 3,5 -dioxo - (2h,4h) - 1,2,4 - triazina,su preparacion y aplicacion como farmaco
FR2662162B1 (fr) Nouveaux derives de l'amino piperidine, de l'amino pyrrolidine et de l'amino perhydroazepine, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
ES8103744A1 (es) Un metodo para la preparacion de derivados de ftalimidina
NZ228028A (en) Ether, thioether, amino or n-containing heterocyclic substituted stilbene derivatives, intermediates, preparation processes and pharmaceutical compositions
MX9202844A (es) 1-indolilalquil-4-( alcoxi-pirimidinil) piperazinas y composicion farmaceutica que las contiene.
ES2096073T3 (es) Derivado de benzamida.
SE9001269D0 (sv) 2-substituted n,n-ditrimethoxybenzoyl piperazines,a preparation process of the same and therapeutic compositions containing them
ATE223411T1 (de) 1-methylcarbapenem-derivate
NO890440L (no) Fremgangsmaate for fremstilling av terapeutisk aktive isokinolinderivater.
ES2089041T5 (es) Compuestos de piridinasulfonamida sustituida, composiciones herbicidas que los contienen, y procedimiento para su preparacion.
DE69702775D1 (de) Chinolinonderivate und diese enthaltende antiallergische Zusammensetzungen
ES2034413T3 (es) Procedimiento para la obtencion de piperraznina n,n'-disubstituida.
FR2616433B1 (fr) Nouveaux derives piperazinyl alkyl piperazine, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
DK0420224T3 (da) Anthihepatopatisk middel
SE8903312D0 (sv) New 2-carbonyl substituted n,n'-di-(trimethoxybenzol)piperazines, process for preparing the same and therapeutical compounds containing them
ATE24915T1 (de) Synergistin-derivate und ihre herstellung.
DE69828087D1 (de) Aminderivate
SE8200679L (sv) 1-bensyl-4-(4-(2-pyrimidinylamino) bensyl 1-2,3-dioxopiperazinderivat, salter derav, forfarande for framstellning derav och karcinostatiska medel der de ingar
SE8903313L (sv) Nya 2-metoxikarbonyl-substituerade n,n'-di-(trimetoxibensoyl)-piperaziner, foerfarande foer framstaellning daerav och terapeutiska foereningar innehaallande dem
SE8405338D0 (sv) (1,3) oxazino (4,3-a) isoquinoline derivatives, process for their preparation and pharmaceutical compositions containing them
EP0273357A3 (en) Fluorine-containing macrolide compounds, pharmaceutical compositions comprising the same and their use for the manufacture of medicaments

Legal Events

Date Code Title Description
NUG Patent has lapsed